梗阻性急性肾损伤风险分层树的推导与内部验证
该研究为回顾性推导与内部验证队列研究,纳入2019年7月1日至12月31日图卢兹大学医院急诊科就诊的KDIGO任何分期的成人急性肾损伤患者,按2:1随机分为推导队列(727例)和内部验证队列(364例)。主要结局为梗阻性急性肾损伤,定义为影像学发现肾积水且需泌尿外科干预或留置Foley导尿管。推导出KIT-FISTO风险分层决策树:腰痛、胁痛或下腹痛者为高危(推导队列风险55%,95%CI 45%至64%;验证队列54%,95%CI 39%至69%);无疼痛但有泌尿外科手术史、腹部肿瘤、孤立功能肾或前列腺增生者为中危(推导队列4%,95%CI 1%至10%;验证队列2%,95%CI 0%至12%);其余>70%患者为低危(观察风险0%,95%CI 0%至1%),低危分类灵敏度推导队列98%(95%CI 92%至100%)、验证队列96%(95%CI 81%至100%)。作者结论为KIT-FISTO已推导并内部验证,但需外部和前瞻性验证后方可实施。
要点
- 急诊科急性肾损伤患者中,无腰痛、胁痛或下腹痛且无泌尿外科手术史、腹部肿瘤、孤立功能肾或前列腺增生史者梗阻性急性肾损伤风险为0%(95%CI 0%至1%)。
- 有腰痛、胁痛或下腹痛的急性肾损伤患者梗阻性急性肾损伤风险推导队列为55%(95%CI 45%至64%),验证队列为54%(95%CI 39%至69%)。
- 无疼痛但有泌尿外科手术史、腹部肿瘤、孤立功能肾或前列腺增生者梗阻性急性肾损伤风险推导队列为4%(95%CI 1%至10%),验证队列为2%(95%CI 0%至12%)。
- 低危分类排除梗阻性急性肾损伤的灵敏度推导队列为98%(95%CI 92%至100%),验证队列为96%(95%CI 81%至100%)。
- KIT-FISTO模型需外部和前瞻性验证后方可实施。
适用人群与场景
- 2019年7月1日至12月31日就诊于图卢兹大学医院急诊科的成人急性肾损伤患者,KDIGO任何分期。
诊断标准与关键阈值
- 梗阻性急性肾损伤定义:影像学发现肾积水且需泌尿外科干预或留置Foley导尿管。
- KIT-FISTO风险分层:有腰痛、胁痛或下腹痛者为高危;无疼痛但有泌尿外科手术史、腹部肿瘤、孤立功能肾或前列腺增生者为中危;其余为低危。
红旗征与不能漏的情况
- 腰痛、胁痛或下腹痛的急性肾损伤患者为高危,梗阻性急性肾损伤风险推导队列55%(95%CI 45%至64%),验证队列54%(95%CI 39%至69%)。
研究设计与关键结果
- 研究类型:回顾性推导与内部验证队列研究;推导队列727例,内部验证队列364例;梗阻性急性肾损伤患病率推导队列9%(64/727),验证队列7%(27/364)。
- 高危(腰痛、胁痛或下腹痛)梗阻性急性肾损伤风险:推导队列55%(95%CI 45%至64%),验证队列54%(95%CI 39%至69%)。
- 中危(无疼痛但有泌尿外科手术史、腹部肿瘤、孤立功能肾或前列腺增生)梗阻性急性肾损伤风险:推导队列4%(95%CI 1%至10%),验证队列2%(95%CI 0%至12%)。
- 低危(其余>70%患者)梗阻性急性肾损伤观察风险:推导队列0%(95%CI 0%至1%),验证队列0%(95%CI 0%至1%);低危分类灵敏度推导队列98%(95%CI 92%至100%),验证队列96%(95%CI 81%至100%)。
证据类型、等级与局限
- 证据类型:回顾性推导与内部验证队列研究。
- 局限:原文未报告局限性。
- 作者结论:KIT-FISTO已推导并内部验证,但需外部和前瞻性验证后方可实施。
对床旁实践的改变
- 对急诊科急性肾损伤患者,KIT-FISTO模型可将无腰痛、胁痛或下腹痛且无泌尿外科手术史、腹部肿瘤、孤立功能肾或前列腺增生史者归为低危,该组梗阻性急性肾损伤观察风险为0%(95%CI 0%至1%)。
- 有腰痛、胁痛或下腹痛的急性肾损伤患者归为高危,梗阻性急性肾损伤风险约55%,需考虑影像学检查及泌尿外科评估。
- 作者认为KIT-FISTO需外部和前瞻性验证后方可实施。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute kidney injury (AKI) is a frequent condition among patients presenting to the emergency department (ED). Obstructive AKI constitutes a urological emergency requiring rapid diagnosis and intervention. The objective of this study was to derive and internally validate a predictive model of obstructive AKI in ED.
METHODS: We conducted a retrospective derivation and internal validation cohort study. Adult patients presenting to the EDs of Toulouse University Hospital with AKI of any Kidney Disease: Improving Global Outcomes (KDIGO) stage between 1 July and 31 December 2019 were eligible. Included patients were randomly assigned in a 2:1 ratio to a derivation cohort (DC) and an internal validation cohort (VC). The primary outcome was obstructive AKI, defined as hydronephrosis identified on imaging and requiring either urological intervention or Foley catheter insertion. A risk stratification decision tree was developed (Kidney Injury Tree For Identification of obSTructive Origin (KIT-FISTO) model).
RESULTS: The prevalence of obstructive AKI was 9% in the DC (64/727) and 7% in the VC (27/364). Patients presenting with lumbar, flank or hypogastric pain were classified as 'high risk' in each cohort, with a corresponding obstructive AKI risk of 55% (95% CI 45% to 64%) and 54% (95% CI 39% to 69%), respectively. Patients without pain but with a history of urinary tract surgery, abdominal cancer, a solitary functional kidney or prostatic hyperplasia were classified as 'moderate risk', with obstructive AKI risks of 4% (95% CI 1% to 10%) and 2% (95% CI 0% to 12%), respectively. All remaining patients (>70%) were classified as 'low risk', with an observed obstructive AKI risk of 0% (95% CI 0% to 1%). 'Low risk' classification had a sensitivity of 98% (95% CI 92% to 100%) and 96% (95% CI 81% to 100%), respectively.
CONCLUSION: The KIT-FISTO was derived and internally validated to predict obstructive AKI in ED, but requires external and prospective validation before implementation.
参考来源
- Balen F, Dubucs X, Roux C, et al. Risk of obstructive acute kidney injury: derivation and internal validation of a risk stratification tree. Emerg Med J. 2026. PMID: 42315320. doi:10.1136/emermed-2025-215861
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。